Kei Bamba

Kei Bamba is an experienced executive in the pharmaceutical industry, currently serving as Executive Officer for the Hypertension Area at CureApp, Inc. since July 2023. Prior to this role, Bamba held various leadership positions, including Corporate Officer and Head of Global BCV Business at SymBio Pharmaceuticals Limited, and Executive Director of Commercial and Head of Specialty Care Business Unit at Amgen. Bamba's career also includes key roles at GSK, Bristol-Myers Squibb, Eli Lilly and Company, and Pfizer, where responsibilities spanned sales, marketing, and strategic project leadership. Bamba has successfully launched multiple products, negotiated promotional contracts, and developed marketing strategies across several therapeutic areas. Bamba holds a degree from Nagoya University.